Capital Growth Management Portfolio holdings
Top Buys
| 1 |
Ford
F
|
+$88.3M |
| 2 |
Stellantis
STLA
|
+$85M |
| 3 |
American Airlines Group
AAL
|
+$65.7M |
| 4 |
Skyworks Solutions
SWKS
|
+$62.3M |
| 5 |
American Tower
AMT
|
+$61.9M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$166M |
| 2 |
HCA Healthcare
HCA
|
+$127M |
| 3 |
Tenet Healthcare
THC
|
+$117M |
| 4 |
Universal Health Services
UHS
|
+$109M |
| 5 |
SNDK
SANDISK CORP
SNDK
|
+$106M |
Sector Composition
| 1 | Consumer Discretionary | 39.44% |
| 2 | Financials | 22.98% |
| 3 | Real Estate | 22.05% |
| 4 | Industrials | 6.68% |
| 5 | Technology | 6.52% |
Similar funds
Capital Growth Management's Q4 2014 Portfolio in Review
As of Q4 2014, Capital Growth Management held 78 positions worth $3.63B, up 2.2% from $3.55B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Capital Growth Management withdrew a net $293M in Q4 2014, closing 19 positions and reducing 12 holdings. Its most notable exit was Gilead Sciences, an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 39% of assets, up from 35% a quarter earlier, followed by Financials and Real Estate.
Against the trend, Capital Growth Management opened a new position in Stellantis worth $86.6M.
- Capital Growth Management's largest Q4 2014 buy was Stellantis: 11,472,154 shares worth $86.6M.
- Capital Growth Management added most to Ford in Q4 2014, an estimated $88.3M increase.
- Capital Growth Management's biggest Q4 2014 reduction was Marriott International, cutting an estimated $83M.
- Capital Growth Management fully exited Gilead Sciences in Q4 2014, selling an estimated $166M.
- Capital Growth Management's ten largest holdings make up 50% of its $3.63B portfolio in Q4 2014.
- Capital Growth Management opened 22 new positions and closed 19 in Q4 2014.
- Capital Growth Management's portfolio value rose 2.2% quarter-over-quarter to $3.63B.
Based on Capital Growth Management's 13F filing for Q4 2014, filed 13 Feb 2015.